CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice

Current combined surgical and neo-adjuvant chemotherapy of primary metastatic osteosarcoma (OS) is ineffective, reflected by a 5-year survival rate of affected patients of less than 20 %. Studies in experimental OS metastasis models pointed to the CXCR4/CXCL12 homing axis as a novel target for OS me...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Brennecke, Patrick, Arlt, Matthias J. E., Campanile, Carmen, Husmann, Knut, Gvozdenovic, Ana, Apuzzo, Tiziana, Thelen, Marcus, Born, Walter, Fuchs, Bruno
Format: Artigo
Idioma:Inglês
Publicat: Springer Netherlands 2014
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3915086/
https://ncbi.nlm.nih.gov/pubmed/24390633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10585-013-9632-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars